Medtronic plc (MDT)
Health Care / Health Care Equipment
S&P 500$79.41
Below average on several measures. Research carefully.
Weak
Score based on 5 of 5 models — high confidence
Is Medtronic plc a Good Investment in 2026?
Medtronic plc (MDT) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Medtronic plc as Strong (7/9). The Lynch model is the least favorable, rating it Neutral. Medtronic plc currently trades below its estimated fair value of $103, suggesting potential upside. Medtronic plc ranks #766 out of 1123 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Fair value above market price. P/E of 21x is moderate for this quality level.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Attractive
Business quality & competitive moat
Graham
Neutral
40% above fair value
Lynch
Neutral
High PEG — growth premium · Slow Grower
Greenblatt
Strong
Top 25% (rank 23%)
Frequently Asked Questions
Is Medtronic plc (MDT) a good investment?
What is Medtronic plc's Piotroski F-Score?
Is MDT overvalued or undervalued?
How does MDT compare to other Health Care stocks?
What do investment models say about MDT?
Similar Stocks
Compare MDT with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer